Tango Therapeutics raises ~$212M via registered direct offering and PIPE

Tango Therapeutics, Inc.

Registered direct offering of 21.0M shares and 3.2M pre-funded warrants at $8.66; net proceeds ~$197M.
Separate PIPE of 1.7M shares at $8.66 for ~$15M total gross proceeds.
Proceeds to advance pipeline and general corporate purposes; cash runway extended into 2028.
Closings expected October 24, 2025; customary conditions apply.
Officers and directors to enter 60-day lock-up agreements per PIPE terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.